Issue 1/2015
Content (26 Articles)
Endometrial cancer: redefining the molecular-targeted approach
Jesse Lopes da Silva, Eduardo Paulino, Mariane Fontes Dias, Andréia Cristina de Melo
A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck
J.-P. Machiels, P. Specenier, J. Krauß, A. Dietz, M.-C. Kaminsky, Y. Lalami, M. Henke, U. Keilholz, R. Knecht, N. J. Skartved, I. D. Horak, P. Pamperin, S. Braun, T. C. Gauler
Sandwich-like neoadjuvant therapy with bevacizumab for locally advanced rectal cancer: a phase II trial
Jian Xiao, Zexian Chen, Wenyun Li, Zuli Yang, Yan Huang, Jian Zheng, Yanhong Deng, Lei Wang, Donglin Ren, Junsheng Peng, Ping Lan, Jianping Wang
Pilot study of modified FOLFOX6 adjuvant chemotherapy for high-risk rectal cancer treated with neoadjuvant chemoradiotherapy
Soo Jung Lee, Byung Woog Kang, Yee Soo Chae, Seung Hyun Cho, Hye Jin Kim, Su Yeon Park, Jun Seok Park, Gyu Seog Choi, Jong Gwang Kim
Direct and indirect targeting of MYC to treat acute myeloid leukemia
Sam Brondfield, Sushma Umesh, Alexandra Corella, Johannes Zuber, Amy R. Rappaport, Coline Gaillard, Scott W. Lowe, Andrei Goga, Scott C. Kogan
Influence of metastatic disease on the usefulness of uracil pharmacokinetics as a screening tool for DPD activity in colorectal cancer patients
Maurice C. van Staveren, Frans Opdam, Henk-Jan Guchelaar, André B. P. van Kuilenburg, Jan Gerard Maring, Hans Gelderblom
Extension of the Calvert formula to patients with severe renal insufficiency
Tomoyo Oguri, Tomoya Shimokata, Isao Ito, Yoshinari Yasuda, Naoto Sassa, Masami Nishiyama, Akinobu Hamada, Yoshinori Hasegawa, Yuichi Ando
Phase II trial of everolimus in patients with refractory metastatic adenocarcinoma of the esophagus, gastroesophageal junction and stomach: possible role for predictive biomarkers
Zev A. Wainberg, Heloisa P. Soares, Ravi Patel, Brian DiCarlo, David J. Park, Andre Liem, He-jing Wang, Lisa Yonemoto, Diego Martinez, Isett Laux, Meghan Brennan, J. Randolph Hecht
Second-line docetaxel for patients with platinum-refractory advanced non-small cell lung cancer and interstitial pneumonia
Naohiro Watanabe, Seiji Niho, Keisuke Kirita, Shigeki Umemura, Shingo Matsumoto, Kiyotaka Yoh, Hironobu Ohmatsu, Koichi Goto
Initial safety report on the tolerability of modified FOLFOX6 as adjuvant therapy in patients with curatively resected stage II or III colon cancer (JFMC41-1001-C2: JOIN trial)
Masahito Kotaka, Takayuki Yoshino, Koji Oba, Katsunori Shinozaki, Tetsuo Touyama, Dai Manaka, Takanori Matsui, Kiyoshi Ishigure, Junichi Hasegawa, Keiji Inoue, Koichi Goto, Junichi Sakamoto, Shigetoyo Saji, Atsushi Ohtsu, Toshiaki Watanabe
Association of fludarabine pharmacokinetic/dynamic biomarkers with donor chimerism in nonmyeloablative HCT recipients
Jeannine S. McCune, Donald E. Mager, Meagan J. Bemer, Brenda M. Sandmaier, Barry E. Storer, Shelly Heimfeld
Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis
Chu Matsuda, Yoshinori Munemoto, Hideyuki Mishima, Naoki Nagata, Mitsuru Oshiro, Masato Kataoka, Junichi Sakamoto, Toru Aoyama, Satoshi Morita, Toru Kono
Interactions of cyclin-dependent kinase inhibitors AT-7519, flavopiridol and SNS-032 with ABCB1, ABCG2 and ABCC1 transporters and their potential to overcome multidrug resistance in vitro
Daniela Cihalova, Frantisek Staud, Martina Ceckova
Development of a new equation to estimate creatinine clearance in cancer patients
Michael P. Chu, Larissa McCaw, Cynthia Stretch, Charles Butts, John Hanson, Michelle Kuzma, Vijaya L. Damaraju, Vickie E. Baracos, Michael B. Sawyer
Comparison of the pharmacokinetics of erlotinib administered in complete fasting and 2 h after a meal in patients with lung cancer
Yuki Katsuya, Yutaka Fujiwara, Kuniko Sunami, Hirofumi Utsumi, Yasushi Goto, Shintaro Kanda, Hidehito Horinouchi, Hiroshi Nokihara, Noboru Yamamoto, Yuki Takashima, Satoko Osawa, Yuichiro Ohe, Tomohide Tamura, Akinobu Hamada
Safety, tolerability, and efficacy of oxaliplatin-based adjuvant chemotherapy after curative resection of hepatic or extrahepatic metastases of Stage IV colorectal cancer
Izuma Nakayama, Mitsukuni Suenaga, Takeru Wakatsuki, Takashi Ichimura, Masato Ozaka, Daisuke Takahari, Eiji Shinozaki, Keisho Chin, Masashi Ueno, Nobuyuki Mizunuma, Toshiharu Yamaguchi
Gemcitabine plus split-dose cisplatin could be a promising alternative to gemcitabine plus carboplatin for cisplatin-unfit patients with advanced urothelial carcinoma
Yi Rang Kim, Jae Lyun Lee, Dalsan You, In Gab Jeong, Cheryn Song, Bumsik Hong, Jun Hyuk Hong, Hanjong Ahn
Phase II study of erlotinib in elderly patients with non-small cell lung cancer harboring epidermal growth factor receptor mutations
Yusuke Inoue, Naoki Inui, Kazuhiro Asada, Masato Karayama, Hiroyuki Matsuda, Koshi Yokomura, Naoki Koshimizu, Shiro Imokawa, Takashi Yamada, Toshihiro Shirai, Norio Kasamatsu, Takafumi Suda
Correlation between BRCA1 and TopBP1 protein expression and clinical outcome of non-small cell lung cancer treated with platinum-based chemotherapy
Lin-run Wang, Lin-Juan He, Yang Wang, Yin-yan Li, Yan Lou, Guo-bing Zhang, Ying Li, Jian Chen
A single-dose PK study of onapristone including the effect of food on absorption
Keyvan Rezai, Didier Chassard, Caroline Denot, Stefan Proniuk, Alexander Zukiwski, Erard Gilles, Haydeé L. Ramos, Alain Patat, Alice Bexon, François Lokiec
Inhibition of prostate cancer cell growth by 3′,4′,5′-trimethoxyflavonol (TMFol)
C. U. F. Kelly Hill, Shaban E. A. Saad, Robert G. Britton, Andreas J. Gescher, Stewart Sale, Karen Brown, Lynne M. Howells
Pharmacodynamic study of axitinib in patients with advanced malignancies assessed with 18F-3′deoxy-3′fluoro-l-thymidine positron emission tomography/computed tomography
Justine Yang Bruce, Peter Colin Scully, Lakeesha L. Carmichael, Jens C. Eickhoff, Scott B. Perlman, Jill Marie Kolesar, Jennifer L. Heideman, Robert Jeraj, Glenn Liu
A phase II study of biweekly S-1 and paclitaxel (SPA) as first-line chemotherapy in patients with metastatic or advanced gastric cancer
Haiping Jiang, Jiong Qian, Peng Zhao, Xiaochen Zhang, Yi Zheng, Chenyu Mao, Yulong Zheng, Linghong Chen, Yao Wang, Haibo Mou, Weijia Fang, Lisong Teng, Nong Xu
Comparison of saliva interleukin-2 concentration to the condition of gums in children with acute lymphoblastic leukaemia during anti-tumour treatment
Elżbieta Pels
Effect of bendamustine in combination with rituximab on QT interval duration in patients with advanced de novo indolent non-Hodgkin or mantle cell lymphoma
John M. Burke, Richard H. C. van der Jagt, Ian W. Flinn, Michael D. Craig, Ling Chen, Joel Morganroth, Mihaela C. Munteanu, David A. MacDonald
Erratum to: Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: Phase II NEOTAX study
Nuriye Ozdemir, Huseyin Abali, Murat Vural, Suayib Yalcin, Berna Oksuzoglu, Burak Civelek, Dilek Oguz, Birol Bostanci, Bulent Yalcin, Nurullah Zengin